Dr. Pedro A. Rodriguez, MD

Dr. Rodriguez practices at Pedro A. Rodriguez M.D., P.A. in Miami, Florida.

Dr. Rodriguez's NPI, 1386710572, was assigned on November 28, 2006. Dr. Rodriguez graduated from Universidad de Salamanca in 1974. Dr. Rodriguez holds Florida license ME0028664.

Dr. Rodriguez's primary practice is Pedro A. Rodriguez M.D., P.A., at 258 NE 27th St, Miami, FL 33137 in Miami-Dade County. The practice phone is (305) 573-9898.

Dr. Rodriguez's primary practice is Pedro A. Rodriguez M.D., P.A. in Miami, Florida. Dr. Rodriguez is also affiliated with Mount Sinai Medical Center. The medical group on file is Pedro Rodriguez, MD. Dmand AI also links Dr. Rodriguez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rodriguez practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Rodriguez's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Rodriguez is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dr. Rodriguez is licensed in Florida.

Dmand AI lists adjustment disease, anxiety, bipolar disorder, depression, psychoses and schizophrenia among the conditions Dr. Rodriguez treats.

CMS data shows 645 Medicare services from Dr. Rodriguez across 4 procedure codes in 2024, for 136 Medicare patients. Medicare paid $45,719 for them.

CMS counts 136 Medicare patients who saw Dr. Rodriguez in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have depression, and 75% have high blood pressure. 59% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rodriguez's median patient age at 68, with 55% women.

In 2024, Dr. Rodriguez wrote 7,253 Medicare Part D claims for 353 patients. 93% of them were for generic drugs. CMS names the drug for 7,022 of them, across 65 drugs with 11 or more claims each, at $932,833 in total drug cost. In 2023, CMS named 7,056 claims across 66 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 56 out of 100 for Dr. Rodriguez for performance year 2024, reported as part of a group. Dr. Rodriguez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rodriguez as offering telehealth.

Dmand AI links 5 papers to Dr. Rodriguez, published from 2011 to 2014. The most frequent topics are Algorithms, Magnetic Resonance Imaging and Signal Processing, Computer-Assisted. Dr. Rodriguez has published most often in IEEE Trans Biomed Eng.

Dmand AI links Dr. Rodriguez to 1 clinical trial. Conditions studied include Pneumovirus Infections and Respiratory Syncytial Virus Infections. Open Payments lists research payments to Dr. Rodriguez that name 1 trial.

CMS Open Payments shows 1,247 general payments to Dr. Rodriguez from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Allergan Inc. paid the most, $47,596. It also lists 9 research payments totaling $1,003 in 2016, naming 1 clinical trial.

Dr. Rodriguez graduated from Universidad de Salamanca in 1974.

Dr. Rodriguez is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.